198 related articles for article (PubMed ID: 16025321)
1. Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species.
Varty GB; Hyde LA; Hodgson RA; Lu SX; McCool MF; Kazdoba TM; Del Vecchio RA; Guthrie DH; Pond AJ; Grzelak ME; Xu X; Korfmacher WA; Tulshian D; Parker EM; Higgins GA
Psychopharmacology (Berl); 2005 Oct; 182(1):132-43. PubMed ID: 16025321
[TBL] [Abstract][Full Text] [Related]
2. The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): comparison of efficacy and side effects across rodent species.
Lu SX; Higgins GA; Hodgson RA; Hyde LA; Del Vecchio RA; Guthrie DH; Kazdoba T; McCool MF; Morgan CA; Bercovici A; Ho GD; Tulshian D; Parker EM; Hunter JC; Varty GB
Eur J Pharmacol; 2011 Jul; 661(1-3):63-71. PubMed ID: 21545797
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors.
Hashiba E; Lambert DG; Jenck F; Wichmann J; Smith G
Life Sci; 2002 Mar; 70(15):1719-25. PubMed ID: 12002517
[TBL] [Abstract][Full Text] [Related]
4. Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function.
Higgins GA; Grottick AJ; Ballard TM; Richards JG; Messer J; Takeshima H; Pauly-Evers M; Jenck F; Adam G; Wichmann J
Neuropharmacology; 2001 Jul; 41(1):97-107. PubMed ID: 11445190
[TBL] [Abstract][Full Text] [Related]
5. The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510).
Varty GB; Lu SX; Morgan CA; Cohen-Williams ME; Hodgson RA; Smith-Torhan A; Zhang H; Fawzi AB; Graziano MP; Ho GD; Matasi J; Tulshian D; Coffin VL; Carey GJ
J Pharmacol Exp Ther; 2008 Aug; 326(2):672-82. PubMed ID: 18492950
[TBL] [Abstract][Full Text] [Related]
6. Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.
Ces A; Reiss D; Walter O; Wichmann J; Prinssen EP; Kieffer BL; Ouagazzal AM
Neuropsychopharmacology; 2012 Jan; 37(2):378-89. PubMed ID: 21881568
[TBL] [Abstract][Full Text] [Related]
7. Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.
Goeldner C; Spooren W; Wichmann J; Prinssen EP
Psychopharmacology (Berl); 2012 Jul; 222(2):203-14. PubMed ID: 22249359
[TBL] [Abstract][Full Text] [Related]
8. Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine.
Reiss D; Wichmann J; Tekeshima H; Kieffer BL; Ouagazzal AM
Eur J Pharmacol; 2008 Jan; 579(1-3):141-8. PubMed ID: 18031727
[TBL] [Abstract][Full Text] [Related]
9. The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys.
Podlesnik CA; Ko MC; Winger G; Wichmann J; Prinssen EP; Woods JH
Psychopharmacology (Berl); 2011 Jan; 213(1):53-60. PubMed ID: 20852848
[TBL] [Abstract][Full Text] [Related]
10. The nociceptin orphanin FQ peptide receptor agonist, Ro64-6198, impairs recognition memory formation through interaction with glutamatergic but not cholinergic receptor antagonists.
Reiss D; Prinssen EP; Wichmann J; Kieffer BL; Ouagazzal AM
Neurobiol Learn Mem; 2012 Oct; 98(3):254-60. PubMed ID: 22982481
[TBL] [Abstract][Full Text] [Related]
11. Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats.
Rutten K; De Vry J; Bruckmann W; Tzschentke TM
Eur J Pharmacol; 2010 Oct; 645(1-3):119-26. PubMed ID: 20674566
[TBL] [Abstract][Full Text] [Related]
12. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.
Walentiny DM; Wiebelhaus JM; Beardsley PM
Drug Alcohol Depend; 2018 Jun; 187():335-342. PubMed ID: 29705547
[TBL] [Abstract][Full Text] [Related]
13. The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid receptor agonist cue.
Recker MD; Higgins GA
J Pharmacol Exp Ther; 2004 Nov; 311(2):652-8. PubMed ID: 15226383
[TBL] [Abstract][Full Text] [Related]
14. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
Rizzi D; Bigoni R; Rizzi A; Jenck F; Wichmann J; Guerrini R; Regoli D; Calo G
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):551-5. PubMed ID: 11383716
[TBL] [Abstract][Full Text] [Related]
15. Distribution of nociceptin and Ro64-6198 activated [35S]-GTPgammaS binding in the rat brain.
Gehlert DR; Gackenheimer SL; Shaw JL
Neuropeptides; 2006 Apr; 40(2):95-105. PubMed ID: 16403422
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys.
Saccone PA; Zelenock KA; Lindsey AM; Sulima A; Rice KC; Prinssen EP; Wichmann J; Woods JH
J Pharmacol Exp Ther; 2016 Apr; 357(1):17-23. PubMed ID: 26801398
[TBL] [Abstract][Full Text] [Related]
17. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.
Jenck F; Wichmann J; Dautzenberg FM; Moreau JL; Ouagazzal AM; Martin JR; Lundstrom K; Cesura AM; Poli SM; Roever S; Kolczewski S; Adam G; Kilpatrick G
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4938-43. PubMed ID: 10758169
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
Ko MC; Woods JH; Fantegrossi WE; Galuska CM; Wichmann J; Prinssen EP
Neuropsychopharmacology; 2009 Aug; 34(9):2088-96. PubMed ID: 19279568
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.
Lutfy K; Eitan S; Bryant CD; Yang YC; Saliminejad N; Walwyn W; Kieffer BL; Takeshima H; Carroll FI; Maidment NT; Evans CJ
J Neurosci; 2003 Nov; 23(32):10331-7. PubMed ID: 14614092
[TBL] [Abstract][Full Text] [Related]
20. Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat.
Obara I; Przewlocki R; Przewlocka B
Pain; 2005 Jul; 116(1-2):17-25. PubMed ID: 15927383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
